| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Bacitracin A 50000 unit powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Bacitracin A 50000 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely recombinant human antithrombin III 1750 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely recombinant human antithrombin III 1750 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Sodium chloride 9 mg/mL solution for irrigation |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Sodium chloride 9 mg/mL solution for irrigation |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| azitromycin, vattenfritt (som azitromycinmonohydrat) 20 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| azitromycin, vattenfritt (som azitromycinmonohydrat) 20 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Lidocaine 50 microgram/mg cutaneous patch |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Lidocaine 50 microgram/mg cutaneous patch |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amoxicillin anhydrous (as amoxicillin) 250 mg chewable tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Amoxicillin anhydrous (as amoxicillin) 250 mg chewable tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely oxygen 0.995 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely oxygen 0.995 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Mezlocillin (as mezlocillin sodium) 3 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mezlocillin (as mezlocillin sodium) 3 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mezlocillin (as mezlocillin sodium) 4 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Mezlocillin (as mezlocillin sodium) 4 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Plicamycin 2.5 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Plicamycin 2.5 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| cefalexin, vattenfritt (som cefalexin) 25 milligram/milliliter, oral lösning |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cefalexin, vattenfritt (som cefalexin) 25 milligram/milliliter, oral lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 20 mg/mL oromucosal spray |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 20 mg/mL oromucosal spray |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefalexin anhydrous (as cefalexin) 25 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefalexin anhydrous (as cefalexin) 25 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 50 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 50 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |